These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1469694)

  • 21. In vivo degradation of human fibrinogen A alpha: detection of cleavage sites and release of antithrombotic peptides.
    Ständker L; Sillard R; Bensch KW; Ruf A; Raida M; Schulz-Knappe P; Schepky AG; Patscheke H; Forssmann WG
    Biochem Biophys Res Commun; 1995 Oct; 215(3):896-902. PubMed ID: 7488058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
    Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ATP on ligand recognition of platelet fibrinogen receptor on GPIIb-IIIa.
    Gawaz MP; Mayinger P; Neumann FJ
    Am J Physiol; 1994 Sep; 267(3 Pt 2):H1098-106. PubMed ID: 8092274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of PEG-tirofiban conjugates.
    Désaubry L; Riché S; Laeuffer P; Cazenave JP
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2028-31. PubMed ID: 18304813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.
    Satoh T; Kouns WC; Yamashita Y; Kamiyama T; Steiner B
    Biochem Biophys Res Commun; 1994 Oct; 204(1):325-32. PubMed ID: 7524499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-peptide fibrinogen receptor antagonists. 7. Design and synthesis of a potent, orally active fibrinogen receptor antagonist.
    Duggan ME; Naylor-Olsen AM; Perkins JJ; Anderson PS; Chang CT; Cook JJ; Gould RJ; Ihle NC; Hartman GD; Lynch JJ
    J Med Chem; 1995 Aug; 38(17):3332-41. PubMed ID: 7650686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel peptides derived from a region of local homology between uteroglobin and lipocortin-1 inhibit platelet aggregation and secretion.
    Vostal JG; Mukherjee AB; Miele L; Shulman NR
    Biochem Biophys Res Commun; 1989 Nov; 165(1):27-36. PubMed ID: 2531581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet "hybrid" peptides analogous to receptor recognition domains on gamma and alpha chains of human fibrinogen.
    Timmons S; Bednarek MA; Kloczewiak M; Hawiger J
    Biochemistry; 1989 Apr; 28(7):2919-23. PubMed ID: 2742820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists.
    Ilveskero S; Lassila R
    Thromb Res; 2006; 117(3):291-7. PubMed ID: 15878612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
    Gachet C; Stierlé A; Cazenave JP; Ohlmann P; Lanza F; Bouloux C; Maffrand JP
    Biochem Pharmacol; 1990 Jul; 40(2):229-38. PubMed ID: 2375765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of a new class of orally active fibrinogen receptor antagonists.
    Klein SI; Molino BF; Czekaj M; Gardner CJ; Chu V; Brown K; Sabatino RD; Bostwick JS; Kasiewski C; Bentley R; Windisch V; Perrone M; Dunwiddie CT; Leadley RJ
    J Med Chem; 1998 Jul; 41(14):2492-502. PubMed ID: 9651154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of an orally active non-peptide fibrinogen receptor antagonist.
    Stilz HU; Jablonka B; Just M; Knolle J; Paulus EF; Zoller G
    J Med Chem; 1996 May; 39(11):2118-22. PubMed ID: 8667355
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability.
    Lanza F; Stierlé A; Gachet C; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1992; 34(1):123-31. PubMed ID: 1523093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
    Sheu JR; Chao SH; Yen MH; Huang TF
    Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A discrete sequence in a platelet integrin is involved in ligand recognition.
    D'Souza SE; Ginsberg MH; Matsueda GR; Plow EF
    Nature; 1991 Mar; 350(6313):66-8. PubMed ID: 2002847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of GPIIb/IIIa antagonists as antithrombotic drugs.
    Nichols AJ; Ruffolo RR; Huffman WF; Poste G; Samanen J
    Trends Pharmacol Sci; 1992 Nov; 13(11):413-7. PubMed ID: 1440877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.
    Peerlinck K; De Lepeleire I; Goldberg M; Farrell D; Barrett J; Hand E; Panebianco D; Deckmyn H; Vermylen J; Arnout J
    Circulation; 1993 Oct; 88(4 Pt 1):1512-7. PubMed ID: 8403299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS; Bruttger O; Pally C; Hagenbach A
    Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.